Four South Florida clinics are enrolling patients in a nationwide trial for a vitamin that may offer a solution for slowing memory loss and halting the progression of Alzheimer’s disease. The trial ...
DEAR DR. ROACH: I have read that thiamine levels in the brains of Alzheimer’s patients showed a deficiency of thiamine. Because of this, it has been suggested that one take a supplement of ...
The Rutgers Robert Wood Johnson Medical School has been chosen as one of about 40 sites to see how well benfotiamine can slow ...
Thiamine, or vitamin B1, plays a pivotal role in sustaining neuronal energy metabolism and has emerged as a critical factor in neuroprotection strategies for Alzheimer's disease. Its active coenzyme ...
The treatment, with a new formulation of a long-used vitamin, was developed by Gary Gibson at Burke Neurological Institute in White Plains. Gibson's decades of research could lead to a better future ...
Researchers seek participants for a federally funded study to determine if benfotiamine, a synthetic version of thiamine (vitamin B1), can help slow ...
With a $45 million grant from the National Institutes of Health and National Institute on Aging, the Alzheimer’s Disease Cooperative Study (ADCS) at University of California San Diego, in ...
Diabetes induced vascular disease is an important cause of blindness, renal failure, and nerve damage. Four major signaling pathways have been implicated in this vascular damage, three of which are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results